Ani Pharmaceuticals (ANIP) Goodwill (2013 - 2026)

Ani Pharmaceuticals (ANIP) has 14 years of Goodwill data on file, last reported at $62.5 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill rose 3.0% year-over-year to $62.5 million; the trailing twelve-month figure through Mar 2026 stood at $62.5 million (up 3.0% YoY), and the FY2025 full-year result was $62.5 million, up 4.15% from the prior year.
• Goodwill held at $62.5 million in Q1 2026, from $62.5 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $62.5 million in Q3 2025 to a low of $28.2 million in Q1 2022.
• A 5-year average of $41.8 million and a median of $28.2 million in 2022 frame the typical range for Goodwill.
• Across the five-year window, Goodwill surged 688.3% in 2022 and changed 0.0% in 2023, its largest moves.
• Tracing ANIP's Goodwill over 5 years: stood at $28.2 million in 2022, then climbed by 0.07% to $28.2 million in 2023, then soared by 112.57% to $60.0 million in 2024, then climbed by 4.15% to $62.5 million in 2025, then changed by 0.0% to $62.5 million in 2026.
• Business Quant data shows ANIP's Goodwill at $62.5 million in Q1 2026, $62.5 million in Q4 2025, and $62.5 million in Q3 2025.